Ramius Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-121,416
Closed -$1.91M 334
2022
Q2
$1.91M Sell
121,416
-556,970
-82% -$8.5M 0.95% 21
2022
Q1
$10.3M Buy
678,386
+453,544
+202% +$6.91M 4.71% 9
2021
Q4
$3.46M Buy
+224,842
New +$2.96M 1.21% 16

Other funds holding NPTN

Ramius Advisors's NPTN Position: Q3 2022 in Review

Ramius Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 121,416 shares — an estimated $1.91M sold.

Ramius Advisors first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $10.3M in Q1 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Ramius Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Ramius Advisors sold 121,416 NEOPHOTONICS CORP shares in Q3 2022, an estimated $1.91M.
  • Ramius Advisors first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
  • Ramius Advisors's NEOPHOTONICS CORP position peaked at $10.3M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Ramius Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.